Macrophage differentiation from monocytes is influenced by the lipid oxidation degree of low density lipoprotein

Mediators of Inflammation

Volumn 2015, Issue , 2015, Pages

  Seo, Jin Won ^a   Yang, Eun Jeong ^a   Yoo, Kyung Hwa ^b   Choi, In Hong ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD86 ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; MANNOSE RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDIZED LOW DENSITY LIPOPROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPID OXIDATION; LIPID PEROXIDATION; MACROPHAGE; MONOCYTE; POLARIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; CELL LINE; CONFOCAL MICROSCOPY; CYTOLOGY; DRUG EFFECTS; LIPID METABOLISM; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; MICROSCOPY, CONFOCAL; MONOCYTES;

EID: 84939178397     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2015/235797     Document Type: Article

References (32)

1. X. H. Yu, Y. C. Fu, D. W. Zhang, K. Yin, and C. K. Tang, "Foam cells in atherosclerosis," Clinica Chimica Acta, vol. 424, pp. 245-252, 2013.
2. K. Z. Boudjeltia, J. Daher, P. van Antwerpen, et al., "Exposure of endothelial cells to physiological levels of myeloperoxidasemodified LDL delays pericellular fibrinolysis," PLoS ONE, vol. 7, no. 6, Article IDe38810, 2012.
3. S. Tsimikas and Y. I. Miller, "Oxidative modification of lipoproteins: mechanisms, role in inflammation and potential clinical applications in cardiovascular disease," Current Pharmaceutical Design, vol. 17, no. 1, pp. 27-37, 2011.
4. L. Cominacini, A. F. Pasini, U. Garbin, et al., "Oxidized low density lipoprotein (ox-LDL) binding to ox-LDL receptor-in endothelial cells induces the activation of NF-kappaB through an increased production of intracellular reactive oxygen species,"The Journal of Biological Chemistry, vol. 275, no. 17, pp. 12633-12638, 2000.
5. M. Essler, M. Retzer, M. Bauer, K. J. Zangl, G. Tigyi, and W. Siess, "Stimulation of platelets and endothelial cells by mildly oxidized LDL proceeds through activation of lysophosphatidic acid receptors and the Rho/Rho-kinase pathway. Inhibition by lovastatin," Annals of theNew York Academy of Sciences, vol. 905, pp. 282-286, 2000.
6. G. K. Hansson, "Inflammatory mechanisms in atherosclerosis," Journal ofThrombosis and Haemostasis, vol. 7, supplement 1, pp. 328-331, 2009.
7. S. A. Isa, J. S. Ruffino, M. Ahluwalia, A. W. Thomas, K. Morris, and R. Webb, "M2 macrophages exhibit higher sensitivity to oxLDL-induced lipotoxicity than other monocyte/macrophage subtypes," Lipids in Health and Disease, vol. 10, article 229, 2011.
8. A. V. Sokolov, V. A. Kostevich, O. L. Runova, et al., "Proatherogenic modification of LDL by surface-boundmyeloperoxidase," Chemistry and Physics of Lipids, vol. 180, pp. 72-80, 2014.
9. K. Z. Boudjeltia, I. Legssyer, P. VanAntwerpenet al., "Triggering of inflammatory response by myeloperoxidase-oxidized LDL," Biochemistry and Cell Biology, vol. 84, no. 5, pp. 805-812, 2006.
10. S. Colin, G. Chinetti-Gbaguidi, and B. Staels, "Macrophage phenotypes in atherosclerosis," Immunological Reviews, vol. 262, no. 1, pp. 153-166, 2014.
11. F. De Paoli, B. Staels, and G. Chinetti-Gbaguidi, "Macrophage phenotypes and their modulation in atherosclerosis," Circulation Journal, vol. 78, no. 8, pp. 1775-1781, 2014.
12. G. K. Hansson and A. Hermansson, "The immune system in atherosclerosis," Nature Immunology, vol. 12, no. 3, pp. 204-212, 2011.
13. A. Radhika and P. R. Sudhakaran, "Upregulation of macrophage-specific functions by oxidized LDL: lysosomal degradation-dependent and -independent pathways," Molecular and Cellular Biochemistry, vol. 372, no. 1-2, pp. 181-190, 2013.
14. G. Lefevre, M. Beljean-Leymarie, F. Beyerle, et al., "Evaluation of lipid peroxidation by measuring thiobarbituric acid reactive substances," Annales de Biologie Clinique (Paris), vol. 56, no. 3, pp. 305-319, 1998.
15. C.-Y. Han and Y. K. Pak, "Oxidation-dependent effects of oxidized LDL: proliferation or cell death," Experimental and Molecular Medicine, vol. 31, no. 4, pp. 165-173, 1999.
16. M. E. Zettler, M. A. Prociuk, J. A. Austria, H. Massaeli, G. Zhong, and G. N. Pierce, "OxLDL stimulates cell proliferation through a general induction of cell cycle proteins," The American Journal of Physiology-Heart and Circulatory Physiology, vol. 284, no. 2, pp. H644-H653, 2003.
17. M. Inoue, H. Itoh, T. Tanaka, et al., "Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-γ," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 4, pp. 560-566, 2001.
18. M. Daigneault, J. A. Preston, H. M. Marriott, M. K. B. Whyte, and D. H. Dockrell, "The identification of markers of macrophage differentiation in PMA-stimulated THP-1 cells and monocyte-derived macrophages," PLoS ONE, vol. 5, no. 1, Article ID e8668, 2010.
19. L. E. Padgett, A. R. Burg, W. Lei, and H. M. Tse, "Loss ofNADPH oxidase-derived superoxide skews macrophage phenotypes to delay type 1 diabetes," Diabetes, vol. 64, no. 3, pp. 937-946, 2015.
20. B. Osterud and E. Bjorklid, "Role of monocytes in atherogenesis," Physiological Reviews, vol. 83, no. 4, pp. 1069-1112, 2003.
21. J. Mauer, B. Chaurasia, J. Goldau, et al., "Signaling by IL-6 promotes alternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin," Nature Immunology, vol. 15, no. 5, pp. 423-430, 2014.
22. D. Duluc, Y. Delneste, F. Tan, et al., "Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells," Blood, vol. 110, no. 13, pp. 4319-4330, 2007.
23. Y. Takada, T. Hisamatsu, N. Kamada, et al., "Monocyte chemoattractant protein-1 contributes to gut homeostasis and intestinal inflammation by composition of IL-10-producing regulatory macrophage subset," Journal of Immunology, vol. 184, no. 5, pp. 2671-2676, 2010.
24. L. C. Becker, "Yin and yang ofMCP-1," Circulation Research, vol. 96, no. 8, pp. 812-814, 2005.
25. H. Morimoto, M. Hirose, M. Takahashi, et al., "MCP-1 induces cardioprotection against ischaemia/reperfusion injury: role of reactive oxygen species," Cardiovascular Research, vol. 78, no. 3, pp. 554-562, 2008.
26. V. Lubrano and S. Balzan, "LOX-1 and ROS, inseparable factors in the process of endothelial damage," Free Radical Research, vol. 48, no. 8, pp. 841-848, 2014.
27. A. Taye and A. A. K. El-Sheikh, "Lectin-like oxidized lowdensity lipoprotein receptor 1 pathways," European Journal of Clinical Investigation, vol. 43, no. 7, pp. 740-745, 2013.
28. J. Oh, A. E. Riek, S. Weng, et al., "Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation," Journal of Biological Chemistry, vol. 287, no. 15, pp. 11629-11641, 2012.
29. D. Hong, Y.-P. Bai, H.-C. Gao, et al., "Ox-LDL induces endothelial cell apoptosis via the LOX-1-dependent endoplasmic reticulum stress pathway," Atherosclerosis, vol. 235, no. 2, pp. 310-317, 2015.
30. F. Zhang, C. Wang, H. Wang, et al., "Ox-LDL promotes migration and adhesion of bonemarrow-derivedmesenchymal stem cells via regulation of MCP-1 expression," Mediators of Inflammation, vol. 2013, Article ID 691023, 11 pages, 2013.
31. E. Cassol, L. Cassetta, C. Rizzi, M. Alfano, and G. Poli, "M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms," The Journal of Immunology, vol. 182, no. 10, pp. 6237-6246, 2009.
32. E. Zajac, B. Schweighofer, T. A. Kupriyanova, et al., "Angiogenic capacity of M1-and M2-polarized macrophages is determined by the levels of TIMP-1 complexedwith their secreted proMMP-9. ," Blood, vol. 122, no. 25, pp. 4054-4067, 2013.